Comparison of high dose calcium and vitamin D3 versus low dose aspirin combined with high dose calcium and vitamin D3 in prevention of preeclampsia: a prospective comparative study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20262555Keywords:
Calcium supplementation, Hypertensive disorders of pregnancy, Maternal outcome, Neonatal outcome, Preeclampsia, Vitamin DAbstract
Background: It is hypothesized that, vitamin D supplementation with or without calcium in pregnancy has important role in reducing risk of preeclampsia. This study was designed to compare the efficacy of high dose calcium, vitamin D3 supplementation with high dose calcium, vitamin D3 combined with low dose aspirin, in prevention of pre-eclampsia.
Methods: This hospital based prospective comparative study was conducted in the Department of Obstetrics and Gynaecology, Koppal Institute of Medical Sciences, Koppal, Karnataka State, India. A total of 210 females with gestational age of 12 weeks attending antenatal check-up divided into three groups of 70 each as group A (calcium and vitamin D3), group B (calcium and vitamin D and aspirin) and group C (routine antenatal medications) were enrolled.
Results: Most of the women in all the three groups were aged between 21 to 25 years (p=0.913). Gestational age of 12 weeks at the start of supplementation was noted in 58.57%, 64.29% and 41.43% of the women in group A, B and C had respectively (p=0.031). Majority of the women (88.33%) of the women in group C had pedal oedema (p<0.001) with presence of urine albumin (52.86%) (p<0.001). Majority of the women in group C (67.14%) had pre-eclampsia and complications compared to 32.86% in group A and 18.57% of in group B (p<0.001). The median gestational age at delivery was statistically similar in all the three groups (p=0.981). Most of the women (37.14%) of the women in group C delivered before 38 weeks of gestational compared to 18.57% in group B and 21.43% of in group A (p=0.032). In group C, 21.43% of the babies required NICU admission compared to 11.43% in group A and 8.57% of in group B (p=0.065). The common indication being preterm birth and low birth weight. Statistically significant difference was observed with respect to NICU stay (p=0.029).
Conclusions: High dose calcium, vitamin D3 combined with low dose aspirin, has significant benefit in preventing the pedal oedema and presence of urine albumin, regulating blood pressure at the time of delivery thereby PE with its associated complications and neonatal morbidity in terms of shorter duration of NICU stay.
References
Chaim SRP, Oliveira SMJ Vasconcellos de, Kimura AF. Pregnancy-induced hypertension and the neonatal outcome. Acta Paul Enferm 2008;21(1):53-8.
Cunningham FG, Hauth JC, Leveno KJ, Gilstrap L, Bloom SL, Wenstrom KD. William’s obstetrics 22nd ed. New York. McGraw Hill Publishers; 2005.
Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066-74.
Incaudo GA. Diagnosis and treatment of allergic rhinitis during pregnancy and lactation. Clin Rev Allergy. 1987;5:325-7.
Lopez-Jaramillo P, Casas JP, Serrano N. Preeclampsia: from epidemiological observations to molecular mechanisms. Braz J Med Biol Res. 2001;34:1227-35.
The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995;345:1455-63.
Carno TA, Nitrini SM. Drug prescription for Pregnant Women: A pharmacoepidemiological study. Cad Saud Publica. 2004;20:1004-13.
Dutta DC. Text book of Obstetrics including Perinatology and Contraception. India: New Central book Agency; 1989.
Sibal BM. Diagnosis, prevention and management of preeclampsia. Obstet Gynecol. 2005;105:402-10.
Brazy JE, Grimm JK, Little VA. Neonatal manifestations of severe maternal hypertension occurring before the thirty sixth week of pregnancy. J Pediatr. 1982;100:265-71.
Henderson JT, Whitlock EP, O’Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the US Preventive Services Task Force. Ann Int Med. 2014;160(10):695-703.
Khedun SM, Moodley J, Naicker T, Maharaj B. Drug management of hypertensive disorders of pregnancy. Pharmacol Ther. 1997;74:221-58.
Gomes F, Ashorn P, Askari S, Belizan JM, Boy E, Cormick G, et al. Calcium supplementation for the prevention of hypertensive disorders of pregnancy: current evidence and programmatic considerations. Ann N Y Acad Sci. 2022;1510(1):52-67.
Chen WY, Sun SF. Clinical efficacy of low-dose aspirin combined with calcium in preventing preeclampsia: A systematic review and meta-analysis. Medicine (Baltimore). 2023;102(34):e34620.
Belizán JM, Villar J, Gonzalez L, Campodonico L, Bergel E. Calcium supplementation to prevent hypertensive disorders of pregnancy. New Engl J Med. 1991;325(20):1399-405.
Woo Kinshella ML, Sarr C, Sandhu A, Bone JN, Vidler M, Moore SE, et al; PRECISE Network. Calcium for pre-eclampsia prevention: A systematic review and network meta-analysis to guide personalised antenatal care. BJOG. 2022;129(11):1833-43.
Giourga C, Papadopoulou SK, Voulgaridou G, Karastogiannidou C, Giaginis C, Pritsa A. Vitamin D Deficiency as a Risk Factor of Preeclampsia during Pregnancy. Diseases. 2023;11(4):158.
Rath W, Fischer T. The Diagnosis and Treatment of Hypertensive Disorders of Pregnancy New Findings for Antenatal and Inpatient Care. Dtsch Arztebl Int. 2009;106:733-8.
Walker JJ. Preeclampsia. Lancet. 2000;356;1260-5.
Kanagasabai S. Biochemical Markers In The Prediction Of Pre-Eclampsia, Are We There Yet? Internet J Gynecol Obstet. 2009;14(1).
Bezerra Maia E Holanda Moura S, Marques Lopes L, Murthi P, da Silva Costa F. Prevention of preeclampsia. J Pregnancy. 2012;2012:435090.
Briceño-Pérez C, Briceño-Sanabria L, Vigil-De Gracia P. Prediction and prevention of preeclampsia. Hypertension in Pregnancy. 2009;28(2):138-55.
Coomarasamy A, Papaioannou S, Gee H, Khan KS. Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a metaanalysis. Obstet Gynecol. 2001;98(5):861-6.
Amin O, Tasnim N, Naeem S. Prevention of pre-eclampsia with low dose aspirin in primigravida. MOJ Women’s Health. 2020;9(1):28-32.
Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007;92:3517-22.
Taherian AA, Taherian A, Shirvani A. Prevention of pre‐eclampsia with low‐ dose aspirin or calcium supplementation. Arch Iranian Med. 2002;5(3):151‐6.
Khan A, Mandal SK, Pal A. Role of high dose calcium in the prevention of preeclampsia. Bangladesh J Obstet Gynaecol. 2013;28(2):66-70.
Atallah A, Lecarpentier E, Goffinet F, Doret-Dion M, Gaucherand P, Tsatsaris V. Aspirin for prevention of preeclampsia. Drugs. 2017;77(17):1819-31.
Sun X, Li H, He X, Li M, Yan P, Xun Y, et al. The association between calcium supplement and preeclampsia and gestational hypertension: a systematic review and meta-analysis of randomized trials. Hypertension Pregnancy. 2019;3(2):129-39.
Khaing W, Vallibhakara SA, Tantrakul V, Vallibhakara O, Rattanasiri S, McEvoy M, et al. Calcium and vitamin D supplementation for prevention of preeclampsia: a systematic review and network meta-analysis. Nutrients. 2017;9(10):1141.
Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145(1):1-33.
Chaudhuri R, Saha MM, Sarkar NC, Pathak S. Role of High Dose Calcium Supplementation in Pre-eclampsia: A Pilot Study. J Clin Diagnostic Res. 2021;15(8):QC22-2.4.
Poonia L, Kochar A, Chaudhary S, Gaur P, Solankim K. A cross sectional study to evaluate serum calcium levels among pregnant women and it's association with preeclampsia and delivery outcomes at tertiary care hospital Bikaner, Rajasthan. Int J Reprod Contracept Obstet Gynecol. 2021;10:2026-30.
Gao Y, Luo D, Wang Q, Lin J. Calcium and vitamin D supplementation in pre-eclampsia: Analysis of effectiveness and safety. Trop J Pharm Res. 2021;20(5):1055-9.
Sinha N, Singh S, Agarwal M, Manjhi PK, Kumar R, Singh SK, Priya A. A Randomized Controlled Study Comparing the Efficacy of 75mg Versus 150mg Aspirin for the Prevention of Preeclampsia in High-Risk Pregnant Women. Cureus. 2023;15(5):e39752.
AlSubai A, Baqai MH, Agha H, Shankarlal N, Javaid SS, Jesrani EK, et al. Vitamin D and preeclampsia: A systematic review and meta-analysis. SAGE Open Med. 2023;11:20503121231212093.
De-Regil LM, Palacios C, Lombardo LK, Pena-Rosas JP, Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2016;CD008873.
Imdad A, Jabeen A, Bhutta ZA. Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: A meta-analysis of studies from developing countries. BMC Public Health. 2011;11(Suppl 3):S18.
Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM, Morris CD, et al. Trial of calcium to prevent pre-eclampsia. N England J Med. 1997;337:69-77.
40.Parveen S, Suseela TL, Yojitha C, Bhargavi K, Deepti M, Devasree S, et al. Comparison of high dose and low dose calcium intake to prevent preeclampsia and eclampsia. Int J Res Rev. 2018;5(8):133-9.
Downloads
Published
How to Cite
Issue
Section
